» Articles » PMID: 37720505

Advancement of Single-cell Sequencing for Clinical Diagnosis and Treatment of Pancreatic Cancer

Overview
Specialty General Medicine
Date 2023 Sep 18
PMID 37720505
Authors
Affiliations
Soon will be listed here.
Abstract

Single-cell sequencing is a high-throughput technique that enables detection of genomic, transcriptomic, and epigenomic information at the individual cell level, offering significant advantages in detecting cellular heterogeneity, precise cell classification, and identifying rare subpopulations. The technique holds tremendous potential in improving the diagnosis and treatment of pancreatic cancer. Moreover, single-cell sequencing provides unique insights into the mechanisms of pancreatic cancer metastasis and cachexia, paving the way for developing novel preventive strategies. Overall, single-cell sequencing has immense potential in promoting early diagnosis, guiding personalized treatment, and preventing complications of pancreatic cancer. Emerging single-cell sequencing technologies will undoubtedly enhance our understanding of the complex biology of pancreatic cancer and pave the way for new directions in its clinical diagnosis and treatment.

Citing Articles

Single-Cell Sequencing: Genomic and Transcriptomic Approaches in Cancer Cell Biology.

Ortega-Batista A, Jaen-Alvarado Y, Moreno-Labrador D, Gomez N, Garcia G, Guerrero E Int J Mol Sci. 2025; 26(5).

PMID: 40076700 PMC: 11901077. DOI: 10.3390/ijms26052074.


A single-cell perspective on immunotherapy for pancreatic cancer: from microenvironment analysis to therapeutic strategy innovation.

Wang R, Liu J, Jiang B, Gao B, Luo H, Yang F Front Immunol. 2024; 15:1454833.

PMID: 39539544 PMC: 11557317. DOI: 10.3389/fimmu.2024.1454833.

References
1.
Sousa C, Biancur D, Wang X, Halbrook C, Sherman M, Zhang L . Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature. 2016; 536(7617):479-83. PMC: 5228623. DOI: 10.1038/nature19084. View

2.
Moffitt R, Marayati R, Flate E, Volmar K, Loeza S, Hoadley K . Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015; 47(10):1168-78. PMC: 4912058. DOI: 10.1038/ng.3398. View

3.
Zhu L, Kan K, Grun J, Hissa B, Yang C, Gyorffy B . GAS2L1 Is a Potential Biomarker of Circulating Tumor Cells in Pancreatic Cancer. Cancers (Basel). 2020; 12(12). PMC: 7765300. DOI: 10.3390/cancers12123774. View

4.
Bertolini G, DAmico L, Moro M, Landoni E, Perego P, Miceli R . Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis. Cancer Res. 2015; 75(17):3636-49. DOI: 10.1158/0008-5472.CAN-14-3781. View

5.
Matozaki T, Murata Y, Okazawa H, Ohnishi H . Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway. Trends Cell Biol. 2009; 19(2):72-80. DOI: 10.1016/j.tcb.2008.12.001. View